Zel Skin & Laser Specialists

    YOUR CONCERNS

    OUR TREATMENTS


VISIBLE BLOOD VESSELS


OUR TREATMENTS
LASER THERAPY
SCLEROTHERAPY

Many skin conditions are caused or exacerbated by abnormal blood vessels located right under the skin. These conditions include port–wine birthmarks, psoriasis, inflammatory acne, angiomas (small, smooth cherry–red bumps) and hemangiomas (raised masses of dilated blood vessels).

Spider veins (Telangiectasia) are also among the common cosmetic problems caused by abnormal blood vessels. These small, enlarged, red, blue or purple blood vessels appear near the skin’s surface, usually on the face and thighs. Their name comes from the fact that their short jagged lines often resemble spider webs. Spider veins may be unattractive, but they are generally harmless. They develop as a result of a number of factors, including heredity, hormonal changes during pregnancy and menopause, weight gain, occupations or activities that involve prolonged sitting or standing, and the use of certain medications.

New technological advances have made it possible to safely and effectively treat spider veins and many other visible blood vessels without surgery.

Laser Therapy: Different lasers are used to treat different kinds of visible blood vessels. The light from the laser targets and coagulates the problem blood vessels while leaving the surrounding skin unchanged. The number of treatments needed to produce the desired results varies depending on the type and location of the blood vessel.

Sclerotherapy: During this non–surgical procedure, unwanted spider veins are injected with a sclerosing solution, which cause them to collapse and fade away.


 
Dr. Brian Zelickson, an internationally recognized expert in skin care,
treats patients from Minneapolis, St. Paul, Edina, Wayzata, Plymouth, St. Louis Park, Minnetonka
and other communities throughout Minnesota.

4100 west 50th street edina mn 55424 P 952–929–8888 F 952–929–9669
2007 Zel Skin & Laser Specialists. All rights reserved. Comments | Privacy
Page Last Updated
11–30–2010